Blue Light Cystoscopy With Cysview® Registry

Launched by PHOTOCURE · Jan 18, 2016

Keywords

ClinConnect Summary

The Blue Light Cystoscopy with Cysview® Registry is a clinical trial aimed at collecting more information about how doctors use a special technique called Blue Light Cystoscopy (BLCC) with a medication called Cysview to examine patients with bladder cancer. This study is currently looking for participants who are adults over the age of 18 and have a suspected or confirmed case of non-muscle invasive bladder cancer, which means the cancer has not grown deeply into the bladder wall.

If you or a family member are interested in participating, it’s important to know that individuals with certain conditions, like porphyria or severe blood in the urine, cannot take part. Participants in this study will help researchers understand how effective this technique is in real-world settings, which could lead to better care for bladder cancer patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult \>18 years old
• • Suspected or known non-muscle invasive bladder cancer on the basis of a prior cystoscopy
• Exclusion Criteria:
• • Porphyria
• • Gross hematuria
• • Known hypersensitivity to hexaminolevulinate or aminolevulinate derivatives